Report Detail

Other Global Veterinary Clostridium Vaccine Market Insights, Forecast to 2025

  • RnM2324305
  • |
  • 16 May, 2019
  • |
  • Global
  • |
  • 125 pages
  • |
  • QYResearch
  • |
  • Other

Global Veterinary Clostridium Vaccine Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Veterinary Clostridium Vaccine Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Veterinary Clostridium Vaccine Market Size Growth Rate by Product
      • 1.4.2 Bovine
      • 1.4.3 Ovine
      • 1.4.4 Caprine
      • 1.4.5 Swine
      • 1.4.6 Poultry
    • 1.5 Market by End User
      • 1.5.1 Global Veterinary Clostridium Vaccine Market Size Growth Rate by End User
      • 1.5.2 Veterinary Clinic
      • 1.5.3 Veterinary Hospital
      • 1.5.4 Veterinary Research Institute
      • 1.5.5 Retail Pharmacy
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Veterinary Clostridium Vaccine Market Size
      • 2.1.1 Global Veterinary Clostridium Vaccine Revenue 2014-2025
      • 2.1.2 Global Veterinary Clostridium Vaccine Sales 2014-2025
    • 2.2 Veterinary Clostridium Vaccine Growth Rate by Regions
      • 2.2.1 Global Veterinary Clostridium Vaccine Sales by Regions
      • 2.2.2 Global Veterinary Clostridium Vaccine Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Veterinary Clostridium Vaccine Sales by Manufacturers
      • 3.1.1 Veterinary Clostridium Vaccine Sales by Manufacturers
      • 3.1.2 Veterinary Clostridium Vaccine Sales Market Share by Manufacturers
      • 3.1.3 Global Veterinary Clostridium Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.2 Veterinary Clostridium Vaccine Revenue by Manufacturers
      • 3.2.1 Veterinary Clostridium Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Veterinary Clostridium Vaccine Revenue Share by Manufacturers (2014-2019)
    • 3.3 Veterinary Clostridium Vaccine Price by Manufacturers
    • 3.4 Veterinary Clostridium Vaccine Manufacturing Base Distribution, Product Types
      • 3.4.1 Veterinary Clostridium Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Veterinary Clostridium Vaccine Product Type
      • 3.4.3 Date of International Manufacturers Enter into Veterinary Clostridium Vaccine Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Veterinary Clostridium Vaccine Sales by Product
    • 4.2 Global Veterinary Clostridium Vaccine Revenue by Product
    • 4.3 Veterinary Clostridium Vaccine Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Veterinary Clostridium Vaccine Breakdown Data by End User

    6 North America

    • 6.1 North America Veterinary Clostridium Vaccine by Countries
      • 6.1.1 North America Veterinary Clostridium Vaccine Sales by Countries
      • 6.1.2 North America Veterinary Clostridium Vaccine Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Veterinary Clostridium Vaccine by Product
    • 6.3 North America Veterinary Clostridium Vaccine by End User

    7 Europe

    • 7.1 Europe Veterinary Clostridium Vaccine by Countries
      • 7.1.1 Europe Veterinary Clostridium Vaccine Sales by Countries
      • 7.1.2 Europe Veterinary Clostridium Vaccine Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Veterinary Clostridium Vaccine by Product
    • 7.3 Europe Veterinary Clostridium Vaccine by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Veterinary Clostridium Vaccine by Countries
      • 8.1.1 Asia Pacific Veterinary Clostridium Vaccine Sales by Countries
      • 8.1.2 Asia Pacific Veterinary Clostridium Vaccine Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Veterinary Clostridium Vaccine by Product
    • 8.3 Asia Pacific Veterinary Clostridium Vaccine by End User

    9 Central & South America

    • 9.1 Central & South America Veterinary Clostridium Vaccine by Countries
      • 9.1.1 Central & South America Veterinary Clostridium Vaccine Sales by Countries
      • 9.1.2 Central & South America Veterinary Clostridium Vaccine Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Veterinary Clostridium Vaccine by Product
    • 9.3 Central & South America Veterinary Clostridium Vaccine by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Veterinary Clostridium Vaccine by Countries
      • 10.1.1 Middle East and Africa Veterinary Clostridium Vaccine Sales by Countries
      • 10.1.2 Middle East and Africa Veterinary Clostridium Vaccine Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Veterinary Clostridium Vaccine by Product
    • 10.3 Middle East and Africa Veterinary Clostridium Vaccine by End User

    11 Company Profiles

    • 11.1 Elanco
      • 11.1.1 Elanco Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Elanco Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Elanco Veterinary Clostridium Vaccine Products Offered
      • 11.1.5 Elanco Recent Development
    • 11.2 Merck
      • 11.2.1 Merck Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Merck Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Merck Veterinary Clostridium Vaccine Products Offered
      • 11.2.5 Merck Recent Development
    • 11.3 Merial
      • 11.3.1 Merial Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merial Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merial Veterinary Clostridium Vaccine Products Offered
      • 11.3.5 Merial Recent Development
    • 11.4 Zoetis
      • 11.4.1 Zoetis Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Zoetis Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Zoetis Veterinary Clostridium Vaccine Products Offered
      • 11.4.5 Zoetis Recent Development
    • 11.5 Advaxis
      • 11.5.1 Advaxis Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Advaxis Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Advaxis Veterinary Clostridium Vaccine Products Offered
      • 11.5.5 Advaxis Recent Development
    • 11.6 Ampliphi
      • 11.6.1 Ampliphi Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Ampliphi Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Ampliphi Veterinary Clostridium Vaccine Products Offered
      • 11.6.5 Ampliphi Recent Development
    • 11.7 Aratana Therapeutics
      • 11.7.1 Aratana Therapeutics Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Aratana Therapeutics Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Aratana Therapeutics Veterinary Clostridium Vaccine Products Offered
      • 11.7.5 Aratana Therapeutics Recent Development
    • 11.8 ARKO Labs
      • 11.8.1 ARKO Labs Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 ARKO Labs Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 ARKO Labs Veterinary Clostridium Vaccine Products Offered
      • 11.8.5 ARKO Labs Recent Development
    • 11.9 Bayer
      • 11.9.1 Bayer Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Bayer Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Bayer Veterinary Clostridium Vaccine Products Offered
      • 11.9.5 Bayer Recent Development
    • 11.10 CanFel Therapeutics
      • 11.10.1 CanFel Therapeutics Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 CanFel Therapeutics Veterinary Clostridium Vaccine Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 CanFel Therapeutics Veterinary Clostridium Vaccine Products Offered
      • 11.10.5 CanFel Therapeutics Recent Development
    • 11.11 Ceva
    • 11.12 Colorado Serum
    • 11.13 Epitopix
    • 11.14 Genus
    • 11.15 Hygieia Biological Laboratories
    • 11.16 Nexvet
    • 11.17 Nuovo Biologics
    • 11.18 Valneva
    • 11.19 Vetoquinol
    • 11.20 Virbac

    12 Future Forecast

    • 12.1 Veterinary Clostridium Vaccine Market Forecast by Regions
      • 12.1.1 Global Veterinary Clostridium Vaccine Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Veterinary Clostridium Vaccine Revenue Forecast by Regions 2019-2025
    • 12.2 Veterinary Clostridium Vaccine Market Forecast by Product
      • 12.2.1 Global Veterinary Clostridium Vaccine Sales Forecast by Product 2019-2025
      • 12.2.2 Global Veterinary Clostridium Vaccine Revenue Forecast by Product 2019-2025
    • 12.3 Veterinary Clostridium Vaccine Market Forecast by End User
    • 12.4 North America Veterinary Clostridium Vaccine Forecast
    • 12.5 Europe Veterinary Clostridium Vaccine Forecast
    • 12.6 Asia Pacific Veterinary Clostridium Vaccine Forecast
    • 12.7 Central & South America Veterinary Clostridium Vaccine Forecast
    • 12.8 Middle East and Africa Veterinary Clostridium Vaccine Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Veterinary Clostridium Vaccine Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Clostridium vaccines are chiefly utilized for a variety of bovine and ovine clostridial diseases such as blackleg, pulpy kidney (enterotoxaemia), black disease, and tetanus. The demand for clostridium vaccine is rising globally owing to the increasing incidence rate of clostridium family diseases and increased awareness regarding zoonotic diseases.
      The demand for clostridium vaccine is rising globally owing to the increasing incidence rate of clostridium family diseases and increased awareness regarding zoonotic diseases. Rising concerns about the mortality of livestock animal and the socioeconomic impact of it on agrarian economies are also increasing the demand for clostridium vaccines in developing countries globally.
      The global Veterinary Clostridium Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Veterinary Clostridium Vaccine market based on company, product type, end user and key regions.

      This report studies the global market size of Veterinary Clostridium Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Clostridium Vaccine in these regions.
      This research report categorizes the global Veterinary Clostridium Vaccine market by top players/brands, region, type and end user. This report also studies the global Veterinary Clostridium Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Elanco
      Merck
      Merial
      Zoetis
      Advaxis
      Ampliphi
      Aratana Therapeutics
      ARKO Labs
      Bayer
      CanFel Therapeutics
      Ceva
      Colorado Serum
      Epitopix
      Genus
      Hygieia Biological Laboratories
      Nexvet
      Nuovo Biologics
      Valneva
      Vetoquinol
      Virbac

      Market size by Product
      Bovine
      Ovine
      Caprine
      Swine
      Poultry
      Market size by End User
      Veterinary Clinic
      Veterinary Hospital
      Veterinary Research Institute
      Retail Pharmacy

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Veterinary Clostridium Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Veterinary Clostridium Vaccine market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Veterinary Clostridium Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Veterinary Clostridium Vaccine submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Veterinary Clostridium Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Veterinary Clostridium Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Veterinary Clostridium Vaccine . Industry analysis & Market Report on Veterinary Clostridium Vaccine is a syndicated market report, published as Global Veterinary Clostridium Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Veterinary Clostridium Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,864.30
      5,796.45
      7,728.60
      4,380.96
      6,571.44
      8,761.92
      536,986.10
      805,479.15
      1,073,972.20
      341,269.81
      511,904.72
      682,539.62
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report